Shiwei Duan

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 44

Top Venues

Human cell

Molecular biomedicine

Journal of experimental & clinical cancer research : CR

Cellular & molecular biology letters

Ningbo University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ningbo University Jan 01 2011

China

Professor :: School of Medicine

Publications

Qing Xia, Jinze Shen, Qurui Wang, Ruixiu Chen, Xinying Zheng, Qibin Yan, Lihua Du, Hanbing Li, Shiwei Duan
Cuproptosis-associated ncRNAs predict breast cancer subtypes. PloS one 19 (2) (2024)
Yue Zheng, Xinming Su, Shiwei Duan
The stiffness of the extracellular matrix is a key factor in tumor progression. MedComm 5 (9) (2024)
Xinming Su, Yaojie Feng, Ruixiu Chen, Shiwei Duan
CircR-loop: a novel RNA:DNA interaction on genome instability. Cellular & molecular biology letters 29 (1) (2024)
Yongming Xia, Ruixiu Chen, Shiwei Duan
Exploring haematopoietic stem cell dynamics through mitochondrial mutation profiling. Molecular biomedicine 5 (1) (2024)
Jinze Shen, Jianqiao Shentu, Chenming Zhong, Qiankai Huang, Shiwei Duan
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy. Clinical and translational medicine 14 (9) (2024)
Xinming Su, Yaojie Feng, Ruixiu Chen, Shiwei Duan
CircR-loop: a novel RNA:DNA interaction on genome instability. Cellular & molecular biology letters 29 (1) (2024)
Chunmeng Rong, Chenhao Liang, Jinze Shen, Yuhua Zhang, Qurui Wang, Fang Yang, Yalu Chen, Yuqing Luo, Meier Gu, Panpan Gao, Yongming Xia, Shiwei Duan
CLLU1 as an emerging biomarker in chronic lymphoid leukemia. Human cell 37 (3) (2024)
Jinze Shen, Xinming Su, Shana Wang, Zehua Wang, Chenming Zhong, Yi Huang, Shiwei Duan
RhoJ: an emerging biomarker and target in cancer research and treatment. Cancer gene therapy (2024)
Yongming Xia, Ruixiu Chen, Shiwei Duan
Exploring haematopoietic stem cell dynamics through mitochondrial mutation profiling. Molecular biomedicine 5 (1) (2024)
Qing Xia, Jinze Shen, Qurui Wang, Ruixiu Chen, Xinying Zheng, Qibin Yan, Lihua Du, Hanbing Li, Shiwei Duan
Cuproptosis-associated ncRNAs predict breast cancer subtypes. PloS one 19 (2) (2024)
Yongming Xia, Ruixiu Chen, Shiwei Duan
Exploring haematopoietic stem cell dynamics through mitochondrial mutation profiling. Molecular biomedicine 5 (1) (2024)
Xinming Su, Yaojie Feng, Ruixiu Chen, Shiwei Duan
CircR-loop: a novel RNA:DNA interaction on genome instability. Cellular & molecular biology letters 29 (1) (2024)
Yongming Xia, Ruixiu Chen, Shiwei Duan
Exploring haematopoietic stem cell dynamics through mitochondrial mutation profiling. Molecular biomedicine 5 (1) (2024)
Chunmeng Rong, Chenhao Liang, Jinze Shen, Yuhua Zhang, Qurui Wang, Fang Yang, Yalu Chen, Yuqing Luo, Meier Gu, Panpan Gao, Yongming Xia, Shiwei Duan
CLLU1 as an emerging biomarker in chronic lymphoid leukemia. Human cell 37 (3) (2024)
Xinming Su, Jianqiao Shentu, Ruixiu Chen, Shiwei Duan
The dual role of SOX17 in the occurrence and development of early colorectal cancer. Molecular biomedicine 5 (1) (2024)
Chunmeng Rong, Chenhao Liang, Jinze Shen, Yuhua Zhang, Qurui Wang, Fang Yang, Yalu Chen, Yuqing Luo, Meier Gu, Panpan Gao, Yongming Xia, Shiwei Duan
CLLU1 as an emerging biomarker in chronic lymphoid leukemia. Human cell (2024)
Xinming Su, Yaojie Feng, Ruixiu Chen, Shiwei Duan
CircR-loop: a novel RNA:DNA interaction on genome instability. Cellular & molecular biology letters 29 (1) (2024)
Qing Xia, Jinze Shen, Qurui Wang, Ruixiu Chen, Xinying Zheng, Qibin Yan, Lihua Du, Hanbing Li, Shiwei Duan
Cuproptosis-associated ncRNAs predict breast cancer subtypes. PloS one 19 (2) (2024)
Chunmeng Rong, Chenhao Liang, Jinze Shen, Yuhua Zhang, Qurui Wang, Fang Yang, Yalu Chen, Yuqing Luo, Meier Gu, Panpan Gao, Yongming Xia, Shiwei Duan
CLLU1 as an emerging biomarker in chronic lymphoid leukemia. Human cell 37 (3) (2024)
Chunmeng Rong, Chenhao Liang, Jinze Shen, Yuhua Zhang, Qurui Wang, Fang Yang, Yalu Chen, Yuqing Luo, Meier Gu, Panpan Gao, Yongming Xia, Shiwei Duan
CLLU1 as an emerging biomarker in chronic lymphoid leukemia. Human cell 37 (3) (2024)
Peijie Zheng, Chuntao Zhou, Yuemin Ding, Shiwei Duan
Disulfidptosis: a new target for metabolic cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Peijie Zheng, Chuntao Zhou, Yue-Min Ding, Bin Liu, Liuyi Lu, Feng Zhu, Shiwei Duan
Nanopore sequencing technology and its applications. MedComm 4 (4) (2023)
Jinze Shen, Xinming Su, Ming Pan, Zehua Wang, Yufei Ke, Qurui Wang, Jingyin Dong, Shiwei Duan
Current insights into the oncogenic roles of lncRNA LINC00355. Cancer innovation 2 (6) (2023)
Qibin Yan, Xinming Su, Yunzhu Chen, Zehua Wang, Wenbo Han, Qing Xia, Yunan Mao, Jiahua Si, Hanbing Li, Shiwei Duan
LINC00941: a novel player involved in the progression of human cancers. Human cell (2023)
Jinze Shen, Xinming Su, Ming Pan, Zehua Wang, Yufei Ke, Qurui Wang, Jingyin Dong, Shiwei Duan
Current insights into the oncogenic roles of lncRNA LINC00355. Cancer innovation 2 (6) (2023)
Peijie Zheng, Chuntao Zhou, Yuemin Ding, Shiwei Duan
Disulfidptosis: a new target for metabolic cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Xinming Su, Xiaoyu Jin, Zehua Wang, Shiwei Duan
Unraveling Exogenous DNA Processing in Cas4-Lacking Crispr Systems: A Novel Bypass Pathway Explored. Advanced biology (2023)
Xinming Su, Peijie Zheng, Shiwei Duan
Tumor-derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming. MedComm 4 (6) (2023)
Peijie Zheng, Chuntao Zhou, Yuemin Ding, Shiwei Duan
Disulfidptosis: a new target for metabolic cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Chenming Zhong, Zijun Xie, Shiwei Duan
H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy. Clinical and translational medicine 13 (10) (2023)
Peijie Zheng, Chuntao Zhou, Yuemin Ding, Shiwei Duan
Disulfidptosis: a new target for metabolic cancer therapy. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jinze Shen, Qurui Wang, Yunan Mao, Wei Gao, Shiwei Duan
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. MedComm 4 (3) (2023)
Jinze Shen, Qurui Wang, Chenhao Liang, Xinming Su, Yufei Ke, Yunan Mao, Jie Fang, Shiwei Duan
Novel Insights into miR-944 in Cancer. Cancers 14 (17) (2022)
Chenming Zhong, Zijun Xie, Jinze Shen, Yunhua Jia, Shiwei Duan
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics. Cells 11 (9) (2022)
Chenming Zhong, Qiudan Zhang, Mingfang Zhang, Yuanlin Qi, Shiwei Duan
LINC00662: A new oncogenic lncRNA with great potential. Journal of cellular physiology (2021)
Tong Gao, Mengsha Zou, Tiancheng Shen, Shiwei Duan
Dysfunction of miR-802 in tumors. Journal of clinical laboratory analysis 35 (11) (2021)
Xiaodong Li, Shufang Bu, Ran Ran Pan, Cong Zhou, Kun Qu, Xiuru Ying, Jie Zhong, Jianhao Xiao, Qian Yuan, Simiao Zhang, Laura Tipton, Yunliang Wang, Youping Deng, Shiwei Duan
The values of AHCY and CBS promoter methylation on the diagnosis of cerebral infarction in Chinese Han population. BMC medical genomics 13 (1) (2020)
Cong Zhou, Xin Zhao, Shiwei Duan
The role of miR-543 in human cancerous and noncancerous diseases. Journal of cellular physiology 236 (1) (2020)
Xiaofeng Xu, Haochang Hu, Ying Lin, Fangzhong Huang, Huihui Ji, Yin Li, Shaoyi Lin, Xiaomin Chen, Shiwei Duan
Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation Meta-Analysis. BioMed research international 2019 (2019)
Ranran Pan, Hang Yu, Jie Dai, Cong Zhou, Xiuru Ying, Jie Zhong, Jun Zhao, Yihan Zhang, Boyi Wu, Yiyi Mao, Dongping Wu, Jieer Ying, Shiwei Duan
Significant association of PRMT6 hypomethylation with colorectal cancer. Journal of clinical laboratory analysis 32 (9) (2018)
Haochang Hu, Tiangong Wang, Ranran Pan, Yong Yang, Bin Li, Cong Zhou, Jun Zhao, Yi Huang, Shiwei Duan
Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer. Pathology oncology research : POR 25 (2) (2018)
Haochang Hu, Xiaoying Chen, Cong Zhou, Bin Li, Yong Yang, Xiuru Ying, Yiyi Mao, Yihan Zhang, Jie Zhong, Jie Dai, Hang Yu, Boyi Wu, Xiaodong Li, Tiangong Wang, Shiwei Duan
Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer. Journal of clinical laboratory analysis 32 (5) (2017)
Youping Deng, Hongwei Wang, Ryuji Hamamoto, Shiwei Duan, Mehdi Pirooznia, Yongsheng Bai
Functional Genomics, Genetics, and Bioinformatics 2016. BioMed research international 2016 (2016)
Youping Deng, Hongwei Wang, Ryuji Hamamoto, David Schaffer, Shiwei Duan
Functional genomics, genetics, and bioinformatics. BioMed research international 2015 (2015)
Limin Xu, Dawei Zheng, Lingyan Wang, Danjie Jiang, Haibo Liu, Leiting Xu, Qi Liao, Lina Zhang, Panpan Liu, Xinbao Shi, Zhaoyang Wang, Lebo Sun, Qingyun Zhou, Ni Li, Yi Huang, Yanping Le, Meng Ye, Guofeng Shao, Shiwei Duan
GCK gene-body hypomethylation is associated with the risk of coronary heart disease. BioMed research international 2014 (2014)
Changyi Wang, Sihan Chen, Tao Zhang, Zhongwei Chen, Shengyuan Liu, Xiaolin Peng, Jianping Ma, Xiaohong Zhong, Yanqiong Yan, Linlin Tang, Yifeng Mai, Liyuan Han, Shiwei Duan
Prediabetes is associated with HNF-4 α P2 promoter polymorphism rs1884613: a case-control study in Han Chinese population and an updated meta-analysis. Disease markers 2014 (2014)

Shiwei Duan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shiwei Duan